See the results of this innovative AML study, leveraging a Phase 1B/2 trial design. We outline the strategies that led to remarkable results and breakdown the lessons we can carry forward: https://lnkd.in/eWNa7Ru8 #clinicaltrials #aml #oncology #clinicalresearch
Precision For Medicine’s Post
More Relevant Posts
-
Flexibility in trial design led to noteworthy results for this AML program. Read how responsiveness helped teams meet milestones and enhance trial efficiency: https://hubs.ly/Q02qZ8BD0 #clinicaltrials #oncology #AML
To view or add a comment, sign in
-
Discover the #QPS Ultimate Guide to #Oncology! Dive into this comprehensive resource filled with the latest insights on #DrugDevelopment, #ClinicalResearch, and the latest news from the QPS #blog. Find the Guide here https://bit.ly/3VnQpWM, or contact us at info@qps.com
To view or add a comment, sign in
-
-
#LatestpublicationofJONT2023 #Title: Beyond Overall Survival: The Value of Oncology- Relevant Endpoints in HTA Body / Payer Decision-Making #checkout: https://lnkd.in/dTjfubNX #Oncology #relevantendpoints #HTAbody #Payer #Decisionmaking #Value #DrugDiscovery #Cancerresearch
To view or add a comment, sign in
-
-
If your in Boston at #octnewengland, stop by booth 58 and discuss with Stephen DeFusco how Precision for Medicine can enable you to have a successful clinical trial in oncology and rare disease!
Leaves aren’t the only things changing. At OCT New England, visit booth 58 to learn key trends that will be shaping the drug development landscape in 2024 and beyond. #clinicalresearch #translationalresearch #oncology Sam Thomas Stephen DeFusco
To view or add a comment, sign in
-
-
Did you know? As an NCODA member, you have a wealth of valuable resources at your fingertips! From clinical guidance to educational materials, it's all on our website. Check out the NCODA Resources page and unlock a world of knowledge: https://lnkd.in/gcRr_g7Z #oncology #resources #passionforpatients
To view or add a comment, sign in
-
-
Last chance to register for our live roundtable discussion, mCRPC update: Best practice and new insights, chaired by Professor Neeraj Agarwal TODAY (19 June) at 15.00-16.00 UTC. Hear from our expert panel on the implications of new data presented at #ASCO2024 https://ow.ly/96YV50SjO0Z #mCRPC #Oncology #ProstateCancer #MedicalUpdates #ClinicalPractice #HealthcareWebinar
To view or add a comment, sign in
-
-
Medical Imaging | Power BI | Data Management | Data Reconciliation | Query Management | Project Support
Advanced #IRT systems tackle the unique #RTSM challenges #oncology trial sponsors face, ensuring trials stay on track and patients continue treatment, even through unexpected (and some expected) changes. Learn how. https://lnkd.in/eGaCKNui #ClinicalTrials #Randomization #TrialSupplyManagement #CalyxIRT #ChooseCalyx
Overcoming oncology trial supply challenges with interactive response technology
To view or add a comment, sign in
-
Ensuring reliable, accurate, and consistent data is the cornerstone of successful clinical trials. By deploying a central lab the customer not only gets access to centralized testing but also to a full range of additional services allowing you to obtain accurate and comparable data in an economical and safe way. Check out the article to learn more 👉 https://lnkd.in/eYe8-VKx #healthscience #oncology #clinicalresearch
To view or add a comment, sign in
-
-
Advanced #IRT systems tackle the unique #RTSM challenges #oncology trial sponsors face, ensuring trials stay on track and patients continue treatment, even through unexpected (and some expected) changes. Learn how. https://lnkd.in/gpSkfWw7 #ClinicalTrials #Randomization #TrialSupplyManagement #CalyxIRT #ChooseCalyx
Overcoming oncology trial supply challenges with interactive response technology
calyx.dsmn8.com
To view or add a comment, sign in
-
Our MEDSIR team is presenting #LUPER trial and two substudies from #PHERGainTrial. We look forward to meeting you! If you're attending #ESMO23, let's chat and explore synergies for strategic #clinicalresearch! #oncology #innovation #bringyourideatolife
To view or add a comment, sign in
-
Anne Kopko, Hasni M'HIDI